2012
DOI: 10.1038/nprot.2012.062
|View full text |Cite
|
Sign up to set email alerts
|

Determination of site-specific glycan heterogeneity on glycoproteins

Abstract: The comprehensive analysis of protein glycosylation is a major requirement for understanding glycoprotein function in biological systems, and is a prerequisite for producing recombinant glycoprotein therapeutics. This protocol describes workflows for the characterization of glycopeptides and their site-specific heterogeneity, showing examples of the analysis of recombinant human erythropoietin (rHuEPO), α1-proteinase inhibitor (A1PI) and immunoglobulin (IgG). Glycoproteins of interest can be proteolytically di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
150
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 173 publications
(156 citation statements)
references
References 44 publications
1
150
0
Order By: Relevance
“…Unlike eukaryotic glycosylation where robust and high-throughput technologies now exist to enrich (20 -22) and characterize both the glycan and peptide component of glycopeptides (23)(24)(25), the diversity (glycan composition and linkage) within bacterial glycosylation systems makes few technologies broadly applicable to all bacterial glycoproteins. Because of this challenge a deeper understanding of the glycan diversity and substrates of glycosylation has been largely unachievable for the majority of known bacterial glycosylation systems.…”
mentioning
confidence: 99%
“…Unlike eukaryotic glycosylation where robust and high-throughput technologies now exist to enrich (20 -22) and characterize both the glycan and peptide component of glycopeptides (23)(24)(25), the diversity (glycan composition and linkage) within bacterial glycosylation systems makes few technologies broadly applicable to all bacterial glycoproteins. Because of this challenge a deeper understanding of the glycan diversity and substrates of glycosylation has been largely unachievable for the majority of known bacterial glycosylation systems.…”
mentioning
confidence: 99%
“…A list of 2325 unique precursors was generated, which were classified as glycopeptides by GRAEZ, and targeted in two subsequent LC-MS runs. Data were acquired with similar instrumental parameters, except the normalized collision energy was 29 and the AGC was set for 3e 6 for MS 1 and 1e 5 for MS 2 scans. All MS 2 spectra from the retrospective experiment were searched for the presence of two marker ions, the TMT reporter ion at 126.1277 daltons or the diagnostic Hex 1 HexNac 1 oxonium ion at 366.1395.…”
Section: Methodsmentioning
confidence: 99%
“…A 60-min linear gradient from 5 to 35% ACN was used. Normalized collision energy was 30, and the AGC was set for 1e 6 for MS 1 and 5e 4 for MS 2 scans. In addition to the retrospective GRAEZ evaluation, prospective GRAEZ testing was also performed.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Changes in glycosylation have been associated with a wide variety of conditions including inherited disease, cancer and infection [7,[16][17][18][19][20]. However, relatively specialized sample preparation, detection methods and data analysis outside the scope of many studies are often required for detailed glycosylation analysis [21,22]. In these cases, the N-glycosylation status of components of a sample is generally ignored.…”
Section: Introductionmentioning
confidence: 99%